Week 12-14 Reverse Flashcards

1
Q

Inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), preventing peptidoglycan cross-linking.

A

Beta-lactams: Mechanism of Action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Include penicillins, cephalosporins, carbapenems, and monobactams.

A

Beta-lactams: Classes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Used parenterally for syphilis and streptococcal infections; not stable in stomach acid.

A

Penicillin G: Use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Oral form used for mild streptococcal infections due to acid stability.

A

Penicillin V: Use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Broad-spectrum oral penicillin used for otitis media, sinusitis, and respiratory tract infections.

A

Amoxicillin: Use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

May cause gastrointestinal upset due to incomplete absorption.

A

Ampicillin: Adverse Effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Extended-spectrum penicillin combination used for serious hospital-acquired and intra-abdominal infections, covers Pseudomonas.

A

Piperacillin-Tazobactam: Use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Used for MSSA skin infections and surgical prophylaxis (e.g., cefazolin, cephalexin).

A

1st Generation Cephalosporins: Use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Effective for respiratory and intra-abdominal infections; active against H. influenzae and anaerobes (e.g., cefuroxime, cefoxitin).

A

2nd Generation Cephalosporins: Use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Broad gram-negative activity; used for meningitis and pneumonia (e.g., ceftriaxone, ceftazidime).

A

3rd Generation Cephalosporins: Use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Effective against Pseudomonas and Enterobacteriaceae; used in febrile neutropenia (e.g., cefepime).

A

4th Generation Cephalosporins: Use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Active against MRSA and resistant gram-positive organisms (e.g., ceftaroline).

A

5th Generation Cephalosporins: Use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Inhibit DNA gyrase (gram-negative) and topoisomerase IV (gram-positive), blocking DNA replication.

A

Fluoroquinolones: Mechanism of Action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Effective against gram-negative infections including Pseudomonas; used for UTIs, GI infections.

A

Ciprofloxacin: Use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Improved gram-positive coverage; used for pneumonia, UTIs, skin infections.

A

Levofloxacin: Use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Covers anaerobes and gram-positives; not used for UTIs due to low urinary concentration.

A

Moxifloxacin: Use

17
Q

Tendon rupture, CNS toxicity, QT prolongation, peripheral neuropathy, dysglycemia.

A

Fluoroquinolones: Adverse Effects

18
Q

Chelation with divalent/trivalent cations (e.g., calcium) reduces absorption.

A

Fluoroquinolones: Absorption Concern

19
Q

Bind to 30S ribosomal subunit, blocking tRNA binding and inhibiting protein synthesis (bacteriostatic).

A

Tetracyclines: Mechanism of Action

20
Q

Tooth discoloration, GI upset, hepatotoxicity, photosensitivity, intracranial hypertension, vestibular effects.

A

Tetracyclines: Adverse Effects

21
Q

Used for tick-borne diseases, respiratory infections, and in penicillin-allergic patients.

A

Doxycycline: Use

22
Q

Preferred in renal impairment due to fecal elimination.

A

Doxycycline: Elimination

23
Q

Bind to 30S subunit, causing misreading of mRNA and disrupting protein synthesis (bactericidal).

A

Aminoglycosides: Mechanism of Action

24
Q

Used for aerobic gram-negative bacilli; ineffective in anaerobic infections.

A

Aminoglycosides: Use

25
Ototoxicity, nephrotoxicity, neuromuscular blockade.
Aminoglycosides: Adverse Effects
26
Reserved for resistant infections due to low susceptibility to enzymatic inactivation.
Amikacin: Role
27
Inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit (bacteriostatic).
Macrolides: Mechanism of Action
28
Used for respiratory infections; once-daily dosing due to long half-life and high tissue penetration.
Azithromycin: Use
29
GI upset, cholestatic jaundice (erythromycin estolate), ototoxicity, QT prolongation.
Macrolides: Adverse Effects
30
Inhibits folate synthesis by blocking dihydropteroate synthase (SMX) and dihydrofolate reductase (TMP).
TMP-SMX: Mechanism of Action
31
Effective against UTIs, MRSA skin infections, and Pneumocystis jirovecii.
TMP-SMX: Use
32
Hyperkalemia, rash, Stevens-Johnson syndrome, hematologic effects.
TMP-SMX: Adverse Effects
33
Effectiveness depends on duration drug concentration stays above MIC (e.g., beta-lactams).
Time-Dependent Killing
34
Higher peak concentrations increase effectiveness (e.g., aminoglycosides, fluoroquinolones).
Concentration-Dependent Killing
35
Antimicrobial activity persists after serum levels fall below MIC (e.g., aminoglycosides).
Post-Antibiotic Effect